Osborne Clarke has advised activpayroll Ltd. on the deal. activpayroll, a leading provider of global payroll and HR solutions, has completed the acquisition of LIMES International (‘LIMES’),...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised QinetiQ on the deal. QinetiQ has sold QinetiQ Space NV, a Belgium-based commercial space business providing design and integration of critical space infrastructure...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Bone Therapeutics on the deal. Bone Therapeutics acquired a majority stake in Medsenic. This combination of Bone Therapeutics and Medsenic has created...
You must be a Standard 1 Year member to access this content.
Osborne Clarke and Ogier advised Industrious on the deal. Industrious, the highest-rated flexible workplace company, acquired 100% of the share capital and voting rights of its...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has assisted in the latest investment in Greenomy. Euroclear, a Belgium-based global provider of Financial Market Infrastructure (FMI) services, is the investor. The investment...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Dutch farming cooperative, Royal Agrifirm Group on the deal. Royal Agrifirm Group signed a five-year unsecured €200,000,000 revolving credit facility arranged by ING...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Bone Therapeutics on the deal. Bone Therapeutics, the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, received...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Delphi Genetics on the deal. Delphi Genetics, a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO) based...
You must be a Standard 1 Year member to access this content.
